HAVCR1 and ischemic stroke: Preclinical assays have shown that inhibiting TIM-1 protects against cerebral ischemia-reperfusion injury [21], while in a clinical study conducted on 4591 subjects, TIM-1 has been associated with a significantly increased incidence of stroke (both ischemic stroke and all-cause stroke) [40].